All News

2071 articles, sorted by publication time.

Biotechnology · global

AI Drug Discovery Bets Again on Neuroimmunology, With Clinical Division of Labor More Critical Than Deal Size

The new collaboration between Insilico and SK Biopharmaceuticals brings generative AI into the difficult terrain where the central nervous system and immunity intersect; what will truly be tested is not only whether algorithms can generate molecules, but whether those molecules can find a credible biological position in human disease.

biotech · global

Bionyra Starts Out With €143 Million, Adding a French Challenger to the Race for New Inflammatory Disease Drugs

In an era when immuno-inflammatory therapies are becoming increasingly precise and increasingly expensive, a large Series A financing puts Bionyra Pharma directly on the early-stage biotech stage; but publicly available information remains limited, and the real test is still whether its candidate antibodies can pass through the narrow gate of clinical evidence.

Biotechnology · global

Medicus Pharma to Update Clinical and Regulatory Progress at BIO Conference, but for a Small Drugmaker the Key Moment Lies in Evidence, Not Slides

A progress report at an industry conference is often a point where capital, the market, and the regulatory path intersect for an early-stage biotech company; but behind an announcement with limited information, what can truly change valuation and medical expectations remains verifiable clinical data.